Trajan collaborates with Monash University for the development of HDX training centre

Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan collaborates with Monash University for the development of HDX training centre

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region. 

About HDX

Hydrogen Deuterium Exchange Mass Spectrometry (HDX-MS) is a powerful technique of ever-increasing importance that provides insight into protein dynamics. HDX-MS studies can be used to connect structure, behaviour and function of a protein, between proteins and drugs, development of life-saving vaccines, as well as the cause and potential resolution of protein misfolding diseases.

In harnessing the power of HDX-MS, insight into the key areas of scientific research like intelligent drug design and development of Biosimilar therapeutics: using HDX-MS can produce better medicines, faster and at a lower price. Day to day, HDX-MS can be used to investigate life-threatening diseases that come from proteins being unstable in the body and speed up medical research by making them more stable in the laboratory too.

 

About Trajan Scientific and Medical

Trajan is a global developer and manufacturer of analytical and life sciences products and devices founded to enrich personal health through scientific tools and solutions, we aim to support science that benefits people. Trajan’s products and solutions are used in the analysis of clinical, pharmaceutical, food, and environmental samples.

Trajan’s strategic direction is driven by a view that the quality of analytical data will become increasingly important in understanding factors that impact human health. That view drives a focus on technologies that enhance the sensitivity, selectivity, reliability and integrity of the sample, the laboratory workflow and ultimately the data and information derived from the analysis. 

 

About Monash University

For more than 60 years, we’ve been working to change the world.

We're tackling climate change, developing new drugs to save millions of lives, using virtual reality to treat addiction, bringing sight to the visually impaired, and so much more.

Our work improves health, solves complex global challenges and empowers whole communities.

We're working every day to create real, lasting global change and we encourage and challenge our students to be at the forefront of innovating for a better future.

Combining world-leading teaching, research, facilities and experiences, Monash University ranks in the world’s top 100 universities.

Visit: monash.edu




Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.
Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Read More

Baker Institute research leads to simple tests for heart and diabetes disease
Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.

Read More

Trajan Scientific and Medical to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.
Trajan Scientific and Medical to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.

October 10, 2022

Trajan Scientific and Medical, and the Baker Heart and Diabetes Institute, have reached an in-principle understanding for Trajan to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.

Read More